Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.8%

1 terminated/withdrawn out of 21 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment Performance

Analytics

N/A

13(81.3%)

Phase 3

2(12.5%)

Phase 4

1(6.3%)

16Total

N/A(13)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials

NCT02750202Phase 3Completed

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

Role: lead

NCT06131749Completed

Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa

Role: collaborator

NCT06982716Not ApplicableRecruiting

Evaluating the Clinical Effectiveness of a Community-based Hearing Aid Fitting Service Delivery Model Facilitated by Community Healthcare Workers (CHWs) Providing Smartphone-based In-situ and Pre-set Hearing Aid Fittings in Low- and Middle-income Communities (LMICs)

Role: lead

NCT05944718Not ApplicableCompleted

Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in South Africa

Role: collaborator

NCT02956031Recruiting

Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.

Role: lead

NCT05337748Not ApplicableCompleted

Clinical Validation of the Lexie Lumen Hearing Aid

Role: collaborator

NCT06431217Completed

Group B Strep Correlates of Protection Study